Medical Xpress November 26, 2021
University of Montreal

The amount of a SARS-CoV-2 genetic material—viral RNA—in the blood is a reliable indicator in detecting which patients will die of the disease, a team led by Université de Montréal medical professor Dr. Daniel Kaufmann has found.

The finding is published today in Science Advances. Kaufmann and his team did the work at the CRCHUM, the research arm of UdeM’s teaching hospital, the Centre hospitalier de l’Université de Montréal.

“In our study, we were able to determine which biomarkers are predictors of mortality in the 60 days following the onset of symptoms,” said Kaufmann, the study’s co-lead author alongside CRCHUM research colleagues Nicolas Chomont and Andrés Finzi.

“Thanks to our data, we have successfully developed and validated a based on...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
23andMe: What If …
Bruker brokers $392M deal for frayed NanoString
Pharma Pulse 4/18/24: Is it Fair Certain Biotech Investors Get an Early Look? The Health and Healthcare of Millennials & more
Pharmacies Should Adopt Proactive Health, Wellness to Help Patients

Share This Article